August 28, 2017 / 9:17 PM / 25 days ago

BRIEF-Abiomed maintains fiscal year 2018 revenue guidance

Aug 28 (Reuters) - Abiomed Inc

* Says ‍is maintaining its fiscal year 2018 revenue guidance of $560 million to $575 million - SEC filing​

* Says is ‍maintaining its fiscal year 2018 guidance for GAAP operating margin in range of 22% to 24%​

* FY2018 revenue view $573.8 million -- Thomson Reuters I/B/E/S Source text: (bit.ly/2xsft1N) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below